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The use of two-dimensional echocardiography in four 
successive views was assessed to determine the optimal 
view for localizing a transvenous percutaneous bioptome 
in 23 consecutive patients undergoing right ventricular 
endomyocardial biopsy. The biopsy catheter tip was 
viewed in 21 (91 %) of the 23 patients. The apical four 
chamber view allowed visualization of the bioptome head 
in 19 patients (83%), the subcostal view in 8 (34%) and 
Percutaneous endomyocardial biopsy is being used with 
greater frequency in a variety of cardiac disorders including 
the diagnosis and follow-up of anthracycline-induced car-
diotoxicity, rejection in cardiac transplant patients, diag-
nosis of primary cardiomyopathy and specific heart muscle 
diseases, such as myocarditis, restrictive versus constrictive 
heart disease and idiopathic chest pain and arrhythmias (1), 
Traditionally, a special bioptome is introduced percuta-
neously through the right internal jugular vein and guided 
into the right ventricular chamber using fluoroscopic con-
trol. The biopsy samples should be obtained from the in-
terventricular septum and not the free wall of the ventricle 
to minimize the chance of transmural perforation (2), 
The use of two-dimensional echocardiography during bi-
opsy was recently reported (3) to provide anatomic infor-
mation and to localize the tip of the bioptome within the 
cardiac chambers, However, the reported data did not in-
clude a systemic description of the usefulness of two-di-
mensional echocardiography or determine the frequency with 
which the tip of the bioptome could be viewed or which 
views were optimal. The purpose of the present study was 
to assess the value of two-dimensional echocardiography 
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tbe long-axis view in 4 (17%). The parasternal short-
axis view was not helpful in any patient. Biplane fluo-
roscopy was not reliable in localizing the bioptome head 
against the interventricular septum and did not identify 
inadvertent septal perforation in one patient. Echocardi-
ography also can be used to immediately identify possible 
complications. 
(J Am Coli CardioI1985,'6:609-11) 
during biopsy and to determine the optimal view for biop-
tome localization in a consecutive series of patients. 
Methods 
Study patients. The study group consisted of 23 con-
secutive patients with congestive heart failure and cardio-
megaly who underwent endomyocardial biopsy. The pa-
tients ranged from 23 to 68 years (mean 50) in age. All 
patients previously underwent left heart catheterization. If 
no significant coronary artery or valvular heart disease was 
found, patients underwent percutaneous endomyocardial bi-
opsy after giving informed consent. 
Procedure. Patients were positioned on the fluoroscopy 
table and a 9F introducer was inserted into the right internal 
jugUlar vein. A Shultz bioptome (Scholton Surgical) was 
inserted and fluoroscopy was used to guide it into the right 
ventricle. One of us (S.K.) assessed the position of the 
bioptome using biplane fluoroscopy according to conven-
tional technique (4) with the intent of placing the tip against 
the interventricular septum by using multiple imaging planes. 
The bioptome tip was subsequently located with a com-
mercially available two-dimensional phased array echocar-
diograph (Diasonic CV 60) using a 2.25 MHz transducer. 
Each patient was scanned in the supine position using a 
long-axis view, a parasternal short-axis view, an apical four 
chamber view and a subcostal view in consecutive fashion. 
The view that provided the clearest image of the bioptome 
head in a particular patient was noted and used for guidance. 
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Figure 1. Apical four chamber view of two-dimensional echo-
cardiograms showing placement of the bioptome head (8) in the 
right ventricle against the interventricular septum. 
During a single biopsy procedure, three tissue samples were 
obtained. The bioptome was initially placed solely under 
fluoroscopic control with the intent of locating the head 
adjacent to the interventricular septum. The placement was 
subsequently assessed by two-dimensional echocardiog-
raphy and the two methods were then compared. 
Each patient was evaluated by two-dimensional echo-
cardiography for pericardial effusion at the completion of 
the procedure. 
Results 
Patient diagnosis. A total of 96 biopsies were per-
formed on 23 consecutive patients under two-dimensional 
echocardiographic and fluoroscopic guidance. Six patients 
had serial biopsies to assess immunosuppressive therapy for 
myocarditis. Final biopsy diagnoses included cardiomy-
opathy in 48%, myocarditis in 35% and nonspecific find-
ings in 17% of the patients. 
Success rate. Clear two-dimensional echocardiographic 
imaging of the bioptome was possible in at least one pro-
jection in all but 2 patients: in 4 patients (17%) in the long-
axis view, in 19 (83%) in the apical four chamber view and 
in 8 (34%) in the subcostal view. The two patients in whom 
the bioptome could not be visualized had an increased an-
teroposterior diameter of the chest. Two other patients with 
similar body habitus had lax abdominal musculature and the 
bioptome tip was only visualized with a subcostal approach. 
Echocardiographic views. In many cases, although the 
shaft of the catheter was seen in all views, the tip was seen 
only in selected views. In no patient was the catheter tip 
identified in all views. Only nine patients had imaging of 
the bioptome tip in two views during one biopsy procedure. 
In 18% of biopsies, after the catheter was positioned fluo-
roscopically, the echocardiogram demonstrated that the tip 
of the catheter was, in fact, in the apex of the right ventricle 
or against the free wall. Frequently, the catheter was seen 
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to move when the bioptome jaws were opened and manip-
ulated. This could not be appreciated in the anteroposterior 
fluoroscopic projection. 
Septal perforation. In one patient, the bioptome was 
seen to perforate the interventricular septum on echocardi-
ography. This patient exhibited restrictive-constrictive 
hemodynamics during initial cardiac catheterization. During 
placement of the catheter, the bioptome tip was seen to pass 
through the interventricular septum from the right ventricle 
into the left ventricle on the apical four chamber view. This 
was not evident on biplane fluoroscopy. The bioptome was 
removed and a successful biopsy was performed without 
complication. The patient was followed up closely with 
serial echocardiograms without incident. The pathologic 
specimen revealed extensive fatty interstitial infiltration. A 
Congo red stain was negative for amyloid deposits. 
Discussion 
The technique of endomyocardial biopsy has proved ef-
fective in patients suspected of having "heart muscle dis-
ease" for both diagnostic purposes and follow-up of ther-
apeutic interventions. The tip of the bioptome is usually 
placed under fluoroscopic guidance (4) to ensure biopsy of 
the interventricular septum and not the free wall. Recently, 
it was shown (3) that two-dimensional echocardiography 
performed during the procedure was useful in localizing the 
bioptome tip in children and adolescents, thus affording 
greater accuracy in visualizing endocardial boundaries and 
intracardiac structures. In this series of 23 adult patients, 
we assessed four separate echocardiographic views in a se-
quential manner to determine how often the bioptome tip 
could be visualized and which view, if any, was superior 
for bioptome localization. We found the apical four chamber 
view to be most useful, revealing a clear image in 19 (83%) 
of the 23 patients. The subcostal view revealed a clear image 
in 8 patients (44%) and the long-axis view in 4 (17%). The 
parasternal short-axis view was not helpful in any of the 
right ventricular biopsies. Overall, the bioptome head was 
visualized in 91 % of cases (21 of 23). The two patients in 
whom the bioptome could not be visualized echocardi-
ographically had increased anteroposterior diameter of the 
chest wall, and adequate studies could not be performed in 
the supine position. 
Fluoroscopy versus echocardiography. We compared 
localization of the bioptome tip with fluoroscopy alone with 
subsequent localization by two-dimensional echocardiog-
raphy. We found that we could not accurately place the 
bioptome against the interventricular septum in 18 % of biop-
sies despite its posterior placement initially on lateral fluo-
roscopy. Frequently, the opening and closing of the biop-
tome jaws just before biopsy changed the position of the 
bioptome head. This change was not noted with fluoroscopy 
but was easily recognized with two-dimensional echocardi-
JACC Vol. 6, No.3 
September 1985:609-11 
ography. We subsequently came to rely on the echocardio-
graphic localization and used fluoroscopy only to place the 
bioptome inside the right ventricular chamber. 
Complications. In one patient, the bioptome was seen 
to perforate the interventricular septum and localize within 
the left ventricular cavity. This was not appreciated with 
fluoroscopy alone, The use of two-dimensional echocardi-
ography also allowed us to visualize the pericardial space 
immediately after the procedure to exclude complications, 
such as hemopericardium, that may occur because of free 
wall perforation, 
STRACHOVSKY ET AL. 611 
ECHOCARDIOGRAPHY DURING MYOCARDIAL BIOPSY 
References 
I. Nippoldt TB. Edwards WO. Holms DR. Reeder GS, Hartzler GO. 
Smith He. Right ventricular endomyocardial biopsy. Mayo Clin Proc 
1982:57:407-18. 
2. Mason lW, Techniques for right and left ventricular endomyocardial 
biopsy. Am 1 Cardiol 1978;41:887-92. 
3. French lW. Popp RL. Pitlick PT. Cardiac localization of transvascular 
bioptome using 2-dimensional ecbocardiography. Am 1 Cardiol 
1983:51:219-23. 
4. Strain lE. Grose RM. Factor SM. Fisher 10. Results of endomyocardial 
biopsy in patients with spontaneous ventricular tachycardia but without 
apparent structural heart disease. Circulation 1983;68: 1171-81. 
